Vilin Bio Med Limited Exempted from Annual Secretarial Compliance Report for FY 2026
Vilin Bio Med Limited has announced that it is not required to submit the Annual Secretarial Compliance Report for the financial year ending March 31, 2026.The company confirmed its exemption status based on the regulations governing listed entities. Vilin Bio Med Limited stated that the corporate governance provisions detailed in various SEBI regulations do not apply to entities that list their specified securities on the SME Exchange.
The company’s exemption is specifically derived from Regulation 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation dictates that listed entities which have listed their specified securities on the SME Exchange are exempt from submitting the Annual Secretarial Compliance Report for the specified financial year.
VILINBIO Stock Price Movement
On Friday, Vilin Bio Med Limited shares slipped by 2.00% to settle at ₹46.55. The stock traded within a discernible range of ₹46.55 to ₹48.45 throughout the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.